PROSTATE CANCER

ACTIVE SURVEILLANCE

WATCHFUL WAITING

 

OBJECTIFIED OBSERVATION

INSIGNIFICANT CANCER is a term used quite frequently in discussions on prostate cancer on the Internet. The usual definition is a T1c diagnosis - that means that nothing was felt during the digital rectal examination - with a PSA of less than 10 ng/ml, a free PSA greater than 15% and a Gleason Grade of 6 or less. Although this kind of diagnosis as very common, many men are not aware of the term insignificant cancer since it is not often referred to by their medical advisors. This piece, written by Donna Pogliano, gives some solid advice to a man who most likely fits the insignificant cancer mould - he had one biopsy needle positive with 1 mm of material with a Gleason of 3+3.

Donna Pogliano is a very determined prostate cancer advocate. She is the co-author of "A Primer on Prostate Cancer, The Empowered Patient's Guide", probably the best book on prostate cancer. A web version of the book is at "A Primer on Prostate Cancer" and is well worth reading. You can usually get the book at Amazon or Barnes and Noble or at the Life Extension Foundation site, whose support saw the book published.

Here's Donna:


From what I'm reading here, you're thinking of undergoing local treatment for one silly millimeter of prostate cancer?


If what you posted about your situation is correctly stated, this is what is meant by "insignificant disease". When they talk about prostate cancer being overdiagnosed and overtreated, they're talking about YOU!


The medical profession may have lured you into the medical mill with a positive biopsy, but you DO still have the option of removing yourself from the treadmill of diagnosis-by-biopsy followed by immediate-local-treatment. I'm sure that either a surgeon or a radiation oncologist would be delighted to treat you because if they only treated patients with your extent of disease their stats would be lookin' REALLY GOOD!


So I have a suggestion. Why don't you start with your evaluation of your options with the simplest and least invasive - Watchful Waiting, otherwise known as Objectified Observation. There isn't a lot of support for that option in medical circles, because it isn't going to result in your insurance company paying thousands of dollars for a treatment you might well have been able to do without. And no one is going to get rich from treating you for the collateral damage resulting from your prostate cancer treatment if you elect Watchful Waiting either. So from a financial standpoint, this is a lose-lose proposition for everyone involved, except for perhaps, YOU.

Before you do anything else, I would get an expert pathologist to review your biopsy material. You can find a link to a list of those in the web version of "A Primer on Prostate Cancer" and also in the book version, "A Primer on Prostate Cancer, The Empowered Patient's Guide". If your 3+3 holds up under expert review, the next step I would take if I were in your situation would be a color-doppler ultrasound with Fred Lee in Michigan or Duke Bahn in Ventura, California. Either of these expert ultrasonographers will be able to see your true extent of disease and make sure that your tumor burden is truly as small as your biopsy report would indicate. Dr. Lee often counsels patients regarding what he feels is the best disease management strategy for the patients he evaluates. Most doctors will outline your options and let you figure it out for yourself, so I think Dr. Lee is a true gem.


The location of the tumor is also an important consideration in determining what course of disease management is appropriate, and this will be evaluated using the color-doppler ultrasound as well. A slow-growing transition zone cancer, for instance, would be unlikely to penetrate the capsule anytime soon, if ever, so Objectified Observation would be even more appropriate for patients with a small tumor located deep within the gland as opposed to a tumor found to be located where they usually are found, at the periphery of the gland.


Periodic ultrasound monitoring and keeping track of the PSA doubling time and velocity will help to keep a handle on what your prostate cancer is doing while you are on a Watchful Waiting regimen. This is why we call it "Objectified Observation". Because you're watching the situation closely so that you can alter the strategy as appropriate.


Objectified Observation, should you be found by expert staging to be a good candidate for it, doesn't mean doing nothing. It means incorporating diet and lifestyle changes designed to make you an inhospitable host to your cancer. It takes work and discipline and not every man is a good fit with this strategy. It also takes some emotional wherewithall to know there is a disease in your body and you aren't taking steps to totally eradicate it, just to control it. On the other hand, men who are good candidates for Watchful Waiting gain peace of mind by undertaking that strategy with a plan for monitoring in place and a contingency Plan B in their back pocket to be used if there is disease progression beyond their comfort zone and beyond the level at which common sense would indicate that treatment is appropriate.


"Eating Your Way to Better Health-The Prostate Forum Nutrition Guide" by Charles E. (Snuffy) Myers, Jr., M.D. Sara Sgarlat Steck, R.T. and Rose Sgarlat Myers, PT., Ph.D. is a great book on nutrition and prostate cancer and is an excellent resource for all prostate cancer patients, not just those who have chosen Watchful Waiting. Here's a link where you can get more information on the book at The Prostate Forum. You can also click on a link at that page to get to a sample issue of the newsletter and there is also a link to use to subscribe.

Obviously, I have no financial interest in whether or not you do that, but I think it will give you a sense of control and mastery over your situation regardless of what disease management strategy you elect, to know what things prostate cancer patients should put into their bodies vs. what things prostate cancer patients would do well to avoid

 

Back to Clippings.